» Articles » PMID: 32131818

The Effect of the Look-back Period for Estimating Incidence Using Administrative Data

Overview
Publisher Biomed Central
Specialty Health Services
Date 2020 Mar 6
PMID 32131818
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The look-back period is needed to define baseline population for estimating incidence. However, short look-back period is known to overestimate incidence of diseases misclassifying prevalent cases to incident cases. The purpose of this study is to evaluate the impact of the various length of look-back period on the observed incidences of uterine leiomyoma, endometriosis and adenomyosis, and to estimate true incidences considering the misclassification errors in the longitudinal administrative data in Korea.

Methods: A total of 319,608 women between 15 to 54 years of age in 2002 were selected from Korea National Health Insurance Services (KNHIS) cohort database. In order to minimize misclassification bias incurred when applying various length of look-back period, we used 11 years of claim data to estimate the incidence by equally setting the look-back period to 11 years for each year using prediction model. The association between the year of diagnosis and the number of prevalent cases with the misclassification rates by each look-back period was investigated. Based on the findings, prediction models on the proportion of misclassified incident cases were developed using multiple linear regression.

Results: The proportion of misclassified incident cases of uterine leiomyoma, endometriosis and adenomyosis were 32.8, 10.4 and 13.6% respectively for the one-year look-back period in 2003. These numbers decreased to 6.3% in uterine leiomyoma and - 0.8% in both endometriosis and adenomyosis using all available look-back periods (11 years) in 2013.

Conclusion: This study demonstrates approaches for estimating incidences considering the different proportion of misclassified cases for various length of look-back period. Although the prediction model used for estimation showed strong R-squared values, follow-up studies are required for validation of the study results.

Citing Articles

Evaluation of Left Truncation and Censoring When Changing the Use of the Codes to Codes in the Danish National Patient Registry.

Korsgaard S, Troelsen F, Veres K, Fuglsang C, Sorensen H Clin Epidemiol. 2024; 16:319-327.

PMID: 38783995 PMC: 11114138. DOI: 10.2147/CLEP.S456171.


Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy.

Minutolo R, Grandaliano G, Di Rienzo P, Snijder R, Degli Esposti L, Perrone V J Nephrol. 2022; 36(2):347-357.

PMID: 36370331 PMC: 9998309. DOI: 10.1007/s40620-022-01475-x.


Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis.

Kim B, Choi A, Kim H, Oh J, Lee J, Kim S J Korean Med Sci. 2022; 37(20):e141.

PMID: 35607738 PMC: 9127427. DOI: 10.3346/jkms.2022.37.e141.


Metastatic Breast Cancer Recurrence after Bone Fractures.

Obi N, Werner S, Thelen F, Becher H, Pantel K Cancers (Basel). 2022; 14(3).

PMID: 35158869 PMC: 8833729. DOI: 10.3390/cancers14030601.


The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada.

Nanditha N, Dong X, McLinden T, Sereda P, Kopec J, Hogg R BMC Med Res Methodol. 2022; 22(1):1.

PMID: 34991473 PMC: 8734246. DOI: 10.1186/s12874-021-01448-x.


References
1.
Worthington J, Gattellari M, Goumas C, Jalaludin B . Differentiating Incident from Recurrent Stroke Using Administrative Data: The Impact of Varying Lengths of Look-Back Periods on the Risk of Misclassification. Neuroepidemiology. 2017; 48(3-4):111-118. DOI: 10.1159/000478016. View

2.
Benchimol E, Guttmann A, Mack D, Nguyen G, Marshall J, Gregor J . Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. J Clin Epidemiol. 2014; 67(8):887-96. DOI: 10.1016/j.jclinepi.2014.02.019. View

3.
Segal J, Powe N . Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006; 4(11):2377-83. DOI: 10.1111/j.1538-7836.2006.02147.x. View

4.
Schmedt N, Khil L, Berger K, Riedel O . Incidence of Multiple Sclerosis in Germany: A Cohort Study Applying Different Case Definitions Based on Claims Data. Neuroepidemiology. 2017; 49(3-4):91-98. DOI: 10.1159/000481990. View

5.
Floyd J, Heckbert S, Weiss N, Carrell D, Psaty B . Use of administrative data to estimate the incidence of statin-related rhabdomyolysis. JAMA. 2012; 307(15):1580-2. PMC: 3483067. DOI: 10.1001/jama.2012.489. View